amiodarone has been researched along with Hemoptysis in 6 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Hemoptysis: Expectoration or spitting of blood originating from any part of the RESPIRATORY TRACT, usually from hemorrhage in the lung parenchyma (PULMONARY ALVEOLI) and the BRONCHIAL ARTERIES.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Two weeks after amiodarone initiation (200 mg/d) hemoptysis occurred and computed tomography revealed unilateral pulmonary infiltrates with ground-glass opacities limited to the lower lobe of the left lung." | 7.81 | [Hemoptysis during concomitant treatment with rivaroxaban and amiodarone in a patient with a history of pulmonary disease]. ( Elikowski, W; Małek, M; Skowroński, M; Skrzywanek, P; Wróblewski, D; Zawilska, K, 2015) |
| "The authors describe a case of a 74-year-old man with advanced coronary heart disease in whom pulmonary hemorrhagic complications during therapy with ticlopidine and subsequently with clopidogrel and amiodarone were observed." | 7.73 | [Recurrent hemoptysis following thienopyridines and amiodarone administration. therapeutic dilemma]. ( Cofta, S; Elikowski, W; Mańczak, J; Nowicki, A; Psuja, P, 2005) |
| "A case of amiodarone pulmonary toxicity (APT) occurring within days of the start of therapy and presenting with hemoptysis is reported." | 7.69 | Very early onset of acute amiodarone pulmonary toxicity presenting with hemoptysis. ( Goldstein, I; Heller, I; Isakov, A; Segev, D; Topilsky, M, 1997) |
| "Amiodarone is a benzofuran derivative with a chemical structure similar to thyroxine." | 5.30 | Amiodarone-associated hemoptysis. ( Brockman, SK; Galindo, L; Kaufman, MS; Morris, RJ; Ravishankar, R; Samuels, FL; Samuels, LE; Thomas, MP, 1998) |
| " Two weeks after amiodarone initiation (200 mg/d) hemoptysis occurred and computed tomography revealed unilateral pulmonary infiltrates with ground-glass opacities limited to the lower lobe of the left lung." | 3.81 | [Hemoptysis during concomitant treatment with rivaroxaban and amiodarone in a patient with a history of pulmonary disease]. ( Elikowski, W; Małek, M; Skowroński, M; Skrzywanek, P; Wróblewski, D; Zawilska, K, 2015) |
| "The authors describe a case of a 74-year-old man with advanced coronary heart disease in whom pulmonary hemorrhagic complications during therapy with ticlopidine and subsequently with clopidogrel and amiodarone were observed." | 3.73 | [Recurrent hemoptysis following thienopyridines and amiodarone administration. therapeutic dilemma]. ( Cofta, S; Elikowski, W; Mańczak, J; Nowicki, A; Psuja, P, 2005) |
| "A case of amiodarone pulmonary toxicity (APT) occurring within days of the start of therapy and presenting with hemoptysis is reported." | 3.69 | Very early onset of acute amiodarone pulmonary toxicity presenting with hemoptysis. ( Goldstein, I; Heller, I; Isakov, A; Segev, D; Topilsky, M, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elikowski, W | 2 |
| Małek, M | 1 |
| Skowroński, M | 1 |
| Wróblewski, D | 1 |
| Skrzywanek, P | 1 |
| Zawilska, K | 1 |
| Blasco, LM | 1 |
| Cofta, S | 1 |
| Nowicki, A | 1 |
| Mańczak, J | 1 |
| Psuja, P | 1 |
| Vizioli, LD | 1 |
| Cho, S | 1 |
| Goldstein, I | 1 |
| Topilsky, M | 1 |
| Segev, D | 1 |
| Isakov, A | 1 |
| Heller, I | 1 |
| Ravishankar, R | 1 |
| Samuels, LE | 1 |
| Kaufman, MS | 1 |
| Samuels, FL | 1 |
| Thomas, MP | 1 |
| Galindo, L | 1 |
| Morris, RJ | 1 |
| Brockman, SK | 1 |
6 other studies available for amiodarone and Hemoptysis
| Article | Year |
|---|---|
[Hemoptysis during concomitant treatment with rivaroxaban and amiodarone in a patient with a history of pulmonary disease].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bronchiectasis; Drug Therapy, Combina | 2015 |
Trepopnea due to amiodarone-induced diffuse alveolar hemorrhage.
Topics: Acenocoumarol; Aged; Amiodarone; Anemia; Anti-Arrhythmia Agents; Anticoagulants; Dyspnea; Hemoptysis | 2013 |
[Recurrent hemoptysis following thienopyridines and amiodarone administration. therapeutic dilemma].
Topics: Aged; Amiodarone; Cardiovascular Agents; Clopidogrel; Coronary Disease; Drug Interactions; Drug Ther | 2005 |
Amiodarone-associated hemoptysis.
Topics: Aged; Aged, 80 and over; Amiodarone; Hemoptysis; Humans; Lung; Lung Diseases, Interstitial; Male | 1994 |
Very early onset of acute amiodarone pulmonary toxicity presenting with hemoptysis.
Topics: Acute Disease; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cough; Dyspnea; Fever; | 1997 |
Amiodarone-associated hemoptysis.
Topics: Amiodarone; Anti-Arrhythmia Agents; Hemoptysis; Humans; Male; Middle Aged | 1998 |